Novel peptidomimetics as BACE-1 inhibitors: Synthesis, molecular modeling, and biological studies-Reference-Cited by-同舟云学术

Novel peptidomimetics as BACE-1 inhibitors: Synthesis, molecular modeling, and biological studies

Published:2013-01 Issue:1 Volume:23 Page:85-89
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Butini Stefania,Gabellieri Emanuele,Brindisi Margherita,Casagni Alice,Guarino Egeria,Huleatt Paul B.,Relitti Nicola,La Pietra Valeria,Marinelli Luciana,Giustiniano Mariateresa,Novellino Ettore,Campiani Giuseppe,Gemma Sandra

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference19 articles.

1. Alzheimer's disease: strategies for disease modification

2. Soluble pool of A? amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

3. Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline

4. A? Oligomers ? a decade of discovery

5. Normal Cellular Processing of the β-Amyloid Precursor Protein Results in the Secretion of the Amyloid β Peptide and Related Moleculesa

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Silico Techniques: Powerful Tool for the Development of Therapeutics;Functional Foods and Therapeutic Strategies for Neurodegenerative Disorders;2022

2. A Close Look at BACE1 Inhibitors for Alzheimer’s Disease Treatment;CNS Drugs;2019-03

3. Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design;Current Neuropharmacology;2018-06-08

4. Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design;Current Neuropharmacology;2018-06-08

5. Synthesis and biological evaluation of 4,6-diphenyl-2-(1H-pyrrol-1-yl)nicotinonitrile analogues of crolibulin and combretastatin A-4;European Journal of Medicinal Chemistry;2018-02